Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3M Buy
21,065
+4,327
+26% +$931K 0.48% 44
2026
Q1
$3.64M Buy
16,738
+325
+2% +$72.1K 0.45% 43
2025
Q4
$3.75M Sell
16,413
-3,322
-17% -$757K 0.49% 43
2025
Q3
$4.57M Buy
19,735
+885
+5% +$180K 0.53% 38
2025
Q2
$3.5M Buy
18,850
+51
+0.3% +$9.48K 0.43% 53
2025
Q1
$3.86M Sell
18,799
-257
-1% -$50K 0.47% 52
2024
Q4
$3.39M Buy
19,056
+5,736
+43% +$1.05M 0.41% 58
2024
Q3
$2.63M Sell
13,320
-741
-5% -$138K 0.37% 68
2024
Q2
$2.41M Buy
14,061
+1,082
+8% +$179K 0.36% 77
2024
Q1
$2.36M Buy
12,979
+2,034
+19% +$351K 0.39% 72
2023
Q4
$1.7M Buy
10,945
+1,365
+14% +$199K 0.34% 80
2023
Q3
$1.43M Buy
9,580
+868
+10% +$127K 0.34% 73
2023
Q2
$1.17M Buy
8,712
+1,334
+18% +$196K 0.3% 87
2023
Q1
$1.18M Buy
7,378
+68
+0.9% +$10.4K 0.41% 65
2022
Q4
$1.09M Buy
7,310
+887
+14% +$136K 0.3% 83
2022
Q3
$862K Buy
6,423
+737
+13% +$106K 0.35% 61
2022
Q2
$871K Buy
+5,686
New +$869K 0.36% 62

Other funds holding ABBV

Naviter Wealth's ABBV Position: Q2 2026 in Review

Naviter Wealth increased its AbbVie (ABBV) stake by 26% in Q2 2026, buying an estimated $931K and bringing the position to 21,065 shares worth $5.3M. The position accounts for 0.48% of the portfolio, ranked #44.

Naviter Wealth first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Naviter Wealth held 21,065 shares of AbbVie worth $5.3M as of Q2 2026.
  • Naviter Wealth bought 4,327 AbbVie shares in Q2 2026, an estimated $931K.
  • AbbVie made up 0.48% of Naviter Wealth's portfolio in Q2 2026, its #44 holding.
  • Naviter Wealth first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Naviter Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.